These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 14672695)
1. Specific inhibition of hepatitis C virus replication by cyclosporin A. Nakagawa M; Sakamoto N; Enomoto N; Tanabe Y; Kanazawa N; Koyama T; Kurosaki M; Maekawa S; Yamashiro T; Chen CH; Itsui Y; Kakinuma S; Watanabe M Biochem Biophys Res Commun; 2004 Jan; 313(1):42-7. PubMed ID: 14672695 [TBL] [Abstract][Full Text] [Related]
2. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. Henry SD; Metselaar HJ; Lonsdale RC; Kok A; Haagmans BL; Tilanus HW; van der Laan LJ Gastroenterology; 2006 Nov; 131(5):1452-62. PubMed ID: 17101321 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868 [TBL] [Abstract][Full Text] [Related]
4. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546 [TBL] [Abstract][Full Text] [Related]
5. Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. Kato T; Date T; Miyamoto M; Sugiyama M; Tanaka Y; Orito E; Ohno T; Sugihara K; Hasegawa I; Fujiwara K; Ito K; Ozasa A; Mizokami M; Wakita T J Clin Microbiol; 2005 Nov; 43(11):5679-84. PubMed ID: 16272504 [TBL] [Abstract][Full Text] [Related]
6. Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. Nakagawa M; Sakamoto N; Tanabe Y; Koyama T; Itsui Y; Takeda Y; Chen CH; Kakinuma S; Oooka S; Maekawa S; Enomoto N; Watanabe M Gastroenterology; 2005 Sep; 129(3):1031-41. PubMed ID: 16143140 [TBL] [Abstract][Full Text] [Related]
7. Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor. Goto K; Watashi K; Inoue D; Hijikata M; Shimotohno K Cancer Sci; 2009 Oct; 100(10):1943-50. PubMed ID: 19659609 [TBL] [Abstract][Full Text] [Related]
8. Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon- alpha. Tanabe Y; Sakamoto N; Enomoto N; Kurosaki M; Ueda E; Maekawa S; Yamashiro T; Nakagawa M; Chen CH; Kanazawa N; Kakinuma S; Watanabe M J Infect Dis; 2004 Apr; 189(7):1129-39. PubMed ID: 15031779 [TBL] [Abstract][Full Text] [Related]
9. [Current approaches for developing new anti-HCV agents and analyses of HCV replication using anti-HCV agents]. Watashi K; Shimotohno K Uirusu; 2005 Jun; 55(1):105-10. PubMed ID: 16308536 [TBL] [Abstract][Full Text] [Related]
10. Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. Namba K; Naka K; Dansako H; Nozaki A; Ikeda M; Shiratori Y; Shimotohno K; Kato N Biochem Biophys Res Commun; 2004 Oct; 323(1):299-309. PubMed ID: 15351737 [TBL] [Abstract][Full Text] [Related]
11. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons. Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001 [TBL] [Abstract][Full Text] [Related]
12. Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells. Murray EM; Grobler JA; Markel EJ; Pagnoni MF; Paonessa G; Simon AJ; Flores OA J Virol; 2003 Mar; 77(5):2928-35. PubMed ID: 12584317 [TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor tacrolimus does not interfere with the suppression of hepatitis C virus infection by interferon-alpha. Pan Q; Metselaar HJ; de Ruiter P; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ Liver Transpl; 2010 Apr; 16(4):520-6. PubMed ID: 20373462 [TBL] [Abstract][Full Text] [Related]
14. Resistance to cyclosporin A derives from mutations in hepatitis C virus nonstructural proteins. Arai M; Tsukiyama-Kohara K; Takagi A; Tobita Y; Inoue K; Kohara M Biochem Biophys Res Commun; 2014 May; 448(1):56-62. PubMed ID: 24751518 [TBL] [Abstract][Full Text] [Related]
15. Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro. Robida JM; Nelson HB; Liu Z; Tang H J Virol; 2007 Jun; 81(11):5829-40. PubMed ID: 17376913 [TBL] [Abstract][Full Text] [Related]
16. [Antiviral activities of ISG20 against hepatitis C virus]. Xu H; Lei Y; Zhong S; Peng FY; Zhou Z; Li K; Ren H Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):33-7. PubMed ID: 23663760 [TBL] [Abstract][Full Text] [Related]
17. Effect of alpha interferon on the hepatitis C virus replicon. Guo JT; Bichko VV; Seeger C J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197 [TBL] [Abstract][Full Text] [Related]
18. Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment. Chang JH; Kato N; Muroyama R; Taniguchi H; Guleng B; Dharel N; Shao RX; Tateishi K; Jazag A; Kawabe T; Omata M Liver Int; 2010 Feb; 30(2):311-8. PubMed ID: 19840259 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha. Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339 [TBL] [Abstract][Full Text] [Related]
20. Diverse effects of cyclosporine on hepatitis C virus strain replication. Ishii N; Watashi K; Hishiki T; Goto K; Inoue D; Hijikata M; Wakita T; Kato N; Shimotohno K J Virol; 2006 May; 80(9):4510-20. PubMed ID: 16611911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]